NO20002435L - Anvendelse av ketolider for forebyggelse av trombotiske komplikasjoner relatert til aterosklerose - Google Patents

Anvendelse av ketolider for forebyggelse av trombotiske komplikasjoner relatert til aterosklerose

Info

Publication number
NO20002435L
NO20002435L NO20002435A NO20002435A NO20002435L NO 20002435 L NO20002435 L NO 20002435L NO 20002435 A NO20002435 A NO 20002435A NO 20002435 A NO20002435 A NO 20002435A NO 20002435 L NO20002435 L NO 20002435L
Authority
NO
Norway
Prior art keywords
ketolides
atherosclerosis
prevention
complications related
thrombotic complications
Prior art date
Application number
NO20002435A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002435D0 (no
Inventor
Francis Petit
Francoise Vacheron
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO20002435D0 publication Critical patent/NO20002435D0/no
Publication of NO20002435L publication Critical patent/NO20002435L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20002435A 1997-11-17 2000-05-11 Anvendelse av ketolider for forebyggelse av trombotiske komplikasjoner relatert til aterosklerose NO20002435L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
PCT/FR1998/002436 WO1999025365A1 (fr) 1997-11-17 1998-11-16 Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (2)

Publication Number Publication Date
NO20002435D0 NO20002435D0 (no) 2000-05-11
NO20002435L true NO20002435L (no) 2000-07-07

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002435A NO20002435L (no) 1997-11-17 2000-05-11 Anvendelse av ketolider for forebyggelse av trombotiske komplikasjoner relatert til aterosklerose

Country Status (35)

Country Link
US (1) US20080139489A1 (enExample)
EP (1) EP1030673B1 (enExample)
JP (1) JP4550273B2 (enExample)
KR (1) KR20010032130A (enExample)
CN (1) CN1286633A (enExample)
AP (1) AP1196A (enExample)
AR (1) AR014119A1 (enExample)
AT (1) ATE271875T1 (enExample)
AU (1) AU744419B2 (enExample)
BG (1) BG104427A (enExample)
BR (1) BR9814199A (enExample)
CA (1) CA2312021C (enExample)
DE (1) DE69825308T2 (enExample)
DZ (1) DZ2654A1 (enExample)
EA (1) EA003322B1 (enExample)
EE (1) EE04095B1 (enExample)
ES (1) ES2224446T3 (enExample)
FR (1) FR2771008B1 (enExample)
GE (1) GEP20032968B (enExample)
HR (1) HRP20000314A2 (enExample)
HU (1) HUP0004507A3 (enExample)
ID (1) ID24940A (enExample)
IL (1) IL136149A0 (enExample)
MA (1) MA26566A1 (enExample)
NO (1) NO20002435L (enExample)
NZ (1) NZ504305A (enExample)
OA (1) OA11411A (enExample)
PL (1) PL340373A1 (enExample)
SK (1) SK7042000A3 (enExample)
TN (1) TNSN98206A1 (enExample)
TR (1) TR200001384T2 (enExample)
TW (1) TW472061B (enExample)
WO (1) WO1999025365A1 (enExample)
YU (1) YU29600A (enExample)
ZA (1) ZA9810357B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
ATE344269T1 (de) * 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
EP1147121B1 (en) * 1999-01-27 2003-12-17 Pfizer Products Inc. Ketolide antibiotics
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
MXPA02009816A (es) 2000-04-04 2003-03-27 Smithkline Beecham Plc Derivados de carbamato de 2-hidroxi-multilina para uso antibacteriano.
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency 14員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
BR9814199A (pt) 2000-09-26
IL136149A0 (en) 2001-05-20
HUP0004507A3 (en) 2001-12-28
ZA9810357B (en) 1999-11-12
OA11411A (fr) 2004-04-20
US20080139489A1 (en) 2008-06-12
FR2771008B1 (fr) 2000-04-28
ID24940A (id) 2000-08-31
GEP20032968B (en) 2003-05-27
CA2312021A1 (fr) 1999-05-27
MA26566A1 (fr) 2004-12-20
CN1286633A (zh) 2001-03-07
KR20010032130A (ko) 2001-04-16
CA2312021C (fr) 2008-08-26
NZ504305A (en) 2002-11-26
EA003322B1 (ru) 2003-04-24
YU29600A (sh) 2003-02-28
EE04095B1 (et) 2003-08-15
SK7042000A3 (en) 2000-12-11
JP2001523644A (ja) 2001-11-27
DE69825308D1 (de) 2004-09-02
BG104427A (en) 2001-02-28
EP1030673B1 (fr) 2004-07-28
DZ2654A1 (fr) 2003-03-22
JP4550273B2 (ja) 2010-09-22
AU1242599A (en) 1999-06-07
EA200000531A1 (ru) 2000-10-30
AU744419B2 (en) 2002-02-21
HRP20000314A2 (en) 2001-02-28
EP1030673A1 (fr) 2000-08-30
HUP0004507A1 (hu) 2001-05-28
PL340373A1 (en) 2001-01-29
TR200001384T2 (tr) 2001-06-21
EE200000244A (et) 2001-06-15
FR2771008A1 (fr) 1999-05-21
AP1196A (en) 2003-08-18
DE69825308T2 (de) 2005-08-04
NO20002435D0 (no) 2000-05-11
ES2224446T3 (es) 2005-03-01
WO1999025365A1 (fr) 1999-05-27
AP2000001825A0 (en) 2000-06-30
TNSN98206A1 (fr) 2005-03-15
ATE271875T1 (de) 2004-08-15
AR014119A1 (es) 2001-02-07
TW472061B (en) 2002-01-11

Similar Documents

Publication Publication Date Title
ATE255819T1 (de) Zusammensetzungen von süssigkeiten
UY24316A1 (es) Composiciones refrescantes
ATE191234T1 (de) Brennölzusammensetzungen
PT817613E (pt) Utilizacao de composicoes compreendendo enzimas estabilizadas
DE69827330D1 (de) Stanolester enthaltende Zusammensetzung
DK0870435T3 (da) Mineralsammensætning
ATE212535T1 (de) Tensidzusammensetzungen
NO990435L (no) Fremstilling av estere som overflateaktive midler
NO985384L (no) FremgangsmÕte for fremstilling av bitumensammensetninger
NO965162L (no) Substituerte aralkyltioalkyltiopyridin til bekjempelse av Helicobacter-bakterier
NO20002435L (no) Anvendelse av ketolider for forebyggelse av trombotiske komplikasjoner relatert til aterosklerose
ATE263230T1 (de) Bleichmittelvorläuferzusammensetzungen
ID17419A (id) Komposisi dekafluoropentana
ID17941A (id) Metode penerapan komposisi pembuat marka jalan
ID18683A (id) Perbaikan yang berhubungan dengankomposisi pemutih
NO992224D0 (no) Additiver til inhibering av gasshydratdannelse
FI991343A0 (fi) Dihydropolyprenolien öljykoostumus
FI980439A0 (fi) Nyttiggoerande av regnvatten fraon yttertak
KR970058559U (ko) 벽 판넬 연결장치
FI930752A7 (fi) Foerfarande foer foergasning av kolhaltiga rester vid mineraloljeraffinering
KR970058605U (ko) 건축용 형틀 패널의 연결장치
KR970005433A (ko) 판넬의 플랜지길이 결정방법
BR9603138A (pt) Tijolo isolante
TW296650U (en) Device to arrange the tiles of mah-jong
NO992379L (no) Additiver til inhibering av dannelsen av gasshydrater